Northwestern Mutual Wealth Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.61M Sell
57,517
-462
-0.8% -$38.1K ﹤0.01% 831
2025
Q4
$4.94M Buy
57,979
+1,971
+4% +$162K ﹤0.01% 774
2025
Q3
$4.36M Buy
56,008
+10,006
+22% +$782K ﹤0.01% 780
2025
Q2
$3.6M Sell
46,002
-48,797
-51% -$3.64M ﹤0.01% 779
2025
Q1
$6.87M Buy
94,799
+44,646
+89% +$3.2M 0.01% 571
2024
Q4
$3.71M Sell
50,153
-10,795
-18% -$756K ﹤0.01% 696
2024
Q3
$4.02M Sell
60,948
-362,946
-86% -$26.4M ﹤0.01% 668
2024
Q2
$39.2M Buy
423,894
+6,093
+1% +$540K 0.04% 233
2024
Q1
$39.9M Buy
417,801
+74,233
+22% +$6.24M 0.04% 229
2023
Q4
$26.2M Buy
343,568
+1,143
+0.3% +$79.5K 0.03% 259
2023
Q3
$23.7M Buy
342,425
+10,986
+3% +$883K 0.03% 259
2023
Q2
$31.3M Buy
331,439
+288,603
+674% +$25.1M 0.04% 221
2023
Q1
$3.54M Buy
42,836
+2,320
+6% +$182K ﹤0.01% 548
2022
Q4
$3.02M Sell
40,516
-7,485
-16% -$577K ﹤0.01% 567
2022
Q3
$3.96M Buy
48,001
+218
+0.5% +$21K 0.01% 471
2022
Q2
$4.54M Sell
47,783
-2,292
-5% -$237K 0.01% 438
2022
Q1
$5.89M Buy
50,075
+5,441
+12% +$610K 0.01% 400
2021
Q4
$5.78M Buy
44,634
+1,532
+4% +$179K 0.01% 386
2021
Q3
$4.88M Sell
43,102
-23,087
-35% -$2.64M 0.01% 387
2021
Q2
$6.86M Buy
66,189
+2,426
+4% +$229K 0.01% 314
2021
Q1
$5.33M Sell
63,763
-26,427
-29% -$2.23M 0.01% 336
2020
Q4
$8.23M Buy
90,190
+1,528
+2% +$127K 0.02% 249
2020
Q3
$7.08M Sell
88,662
-4,256
-5% -$332K 0.02% 248
2020
Q2
$6.42M Buy
92,918
+3,578
+4% +$254K 0.02% 241
2020
Q1
$5.62M Buy
89,340
+9,516
+12% +$686K 0.02% 238
2019
Q4
$6.21M Sell
79,824
-5,634
-7% -$440K 0.02% 243
2019
Q3
$6.26M Buy
85,458
+612
+0.7% +$43K 0.02% 236
2019
Q2
$5.22M Buy
84,846
+33,822
+66% +$2.05M 0.02% 251
2019
Q1
$3.25M Buy
51,024
+24,552
+93% +$1.4M 0.01% 292
2018
Q4
$1.35M Buy
26,472
+1,620
+7% +$82K 0.01% 393
2018
Q3
$1.44M Buy
24,852
+1,920
+8% +$93.9K 0.01% 370
2018
Q2
$1.11M Buy
22,932
+2,307
+11% +$108K 0.01% 391
2018
Q1
$959K Buy
20,625
+3,813
+23% +$166K 0.01% 409
2017
Q4
$632K Sell
16,812
-6,216
-27% -$228K ﹤0.01% 464
2017
Q3
$839K Buy
23,028
+3,516
+18% +$134K 0.01% 387
2017
Q2
$769K Buy
19,512
+2,319
+13% +$84.6K 0.01% 396
2017
Q1
$539K Sell
17,193
-9,966
-37% -$312K ﹤0.01% 436
2016
Q4
$858K Buy
+27,159
New +$880K 0.01% 356
2016
Q3
Sell
-31,251
Closed -$1.04M 593
2016
Q2
$1.04M Buy
31,251
+21
+0.1% +$718 0.01% 305
2016
Q1
$1M Sell
31,230
-159,834
-84% -$4.41M 0.02% 282
2015
Q4
$5.03M Buy
191,064
+12,870
+7% +$334K 0.1% 153
2015
Q3
$4.22M Buy
178,194
+33,480
+23% +$808K 0.1% 156
2015
Q2
$3.44M Buy
144,714
+140,850
+3,645% +$3.18M 0.09% 161
2015
Q1
$92K Buy
3,864
+564
+17% +$12.7K ﹤0.01% 551
2014
Q4
$70K Sell
3,300
-1,794
-35% -$36K ﹤0.01% 585
2014
Q3
$87K Sell
5,094
-150
-3% -$2.37K ﹤0.01% 521
2014
Q2
$75K Hold
5,244
﹤0.01% 532
2014
Q1
$65K Buy
5,244
+1,110
+27% +$12.8K ﹤0.01% 563
2013
Q4
$45K Buy
4,134
+330
+9% +$3.72K ﹤0.01% 623
2013
Q3
$44K Hold
3,804
﹤0.01% 583
2013
Q2
$43K Buy
+3,804
New +$45K ﹤0.01% 583

Other funds holding EW

Northwestern Mutual Wealth Management's EW Position: Q1 2026 in Review

Northwestern Mutual Wealth Management reduced its Edwards Lifesciences (EW) stake by 0.8% in Q1 2026, selling an estimated $38.1K and leaving 57,517 shares worth $4.61M. The position accounts for ﹤0.01% of the portfolio, ranked #831.

Northwestern Mutual Wealth Management first reported a position in EW in Q2 2013 and has held it in 51 quarters since. The position peaked at $39.9M in Q1 2024. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Northwestern Mutual Wealth Management held 57,517 shares of Edwards Lifesciences worth $4.61M as of Q1 2026.
  • Northwestern Mutual Wealth Management sold 462 Edwards Lifesciences shares in Q1 2026, an estimated $38.1K.
  • Edwards Lifesciences made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #831 holding.
  • Northwestern Mutual Wealth Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 51 quarters since.
  • Northwestern Mutual Wealth Management's Edwards Lifesciences position peaked at $39.9M in Q1 2024.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.